EMA: Q&A Update [BE/BA News]
Dear All
Yesterday EMEA has also published first set of product-specific bioequivalence guidance similar to that of FDA.
In the first set BE guidance of following products has been updated
Yesterday EMEA has also published first set of product-specific bioequivalence guidance similar to that of FDA.
In the first set BE guidance of following products has been updated
- Capecitabine
- Carglumic acid
- Dasatinib
- Emtricitabine/tenofovir disoproxil
- Erlotinib
- Imatinib
- Memantine
- Miglustat
- Oseltamivir
- Posaconazole
- Repaglinide
- Sirolimus
- Sorafenib
- Tadalafil
- Telithromycine
- Voriconazole
—
~A happy Soul~
~A happy Soul~
Complete thread:
- EMA: Q&A Update Helmut 2013-11-15 13:53
- EMA: Q&A Updateluvblooms 2013-11-16 06:36
- The early bird gets the worm Helmut 2013-11-16 12:20
- The early bird gets the worm but luvblooms 2013-11-16 14:23
- Lambda Therapeutic Ltd.? Helmut 2013-11-16 15:25
- Lambda Therapeutic Ltd.? luvblooms 2013-11-16 19:24
- Lambda Therapeutic Ltd.? Helmut 2013-11-16 15:25
- The early bird gets the worm but luvblooms 2013-11-16 14:23
- The early bird gets the worm Helmut 2013-11-16 12:20
- EMA: Q&A Update; Expected studies for Quetiapine PR Tablets viveksraut 2018-08-06 14:42
- EMA: Q&A Updateluvblooms 2013-11-16 06:36